Mascoma Wealth Management’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.95K Hold
2025
Q1
$1.36K Buy
2024
Q3
Sell
2024
Q2
$2.21K Hold
2024
Q1
$2.79K Hold
2023
Q4
$2.57K Hold
2023
Q3
$1.86K Hold
2023
Q2
$2.17K Sell
2023
Q1
$14.2K Hold
2022
Q4
$11.8K Buy
2022
Q3
$16K Hold
2022
Q2
$15K Hold
2022
Q1
$16K Buy